2-pyrazolin-5-ones
Chemical compounds having structural formula (I) and physiologically acceptable salts thereof, are inhibitors of serine/threonine and tyrosine kinase activity. Several of the tyrosine kinases, whose activity is inhibited by these chemical compounds, are involved in angiogenic processes. Thus, these...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | DAVID J. CALDERWOOD LEE ARNOLD MARINA M. MOSET JOSE MARIA CASTELLANO BERLANGA ISABEL F. FERNANDEZ PAUL RAFFERTY |
| description | Chemical compounds having structural formula (I) and physiologically acceptable salts thereof, are inhibitors of serine/threonine and tyrosine kinase activity. Several of the tyrosine kinases, whose activity is inhibited by these chemical compounds, are involved in angiogenic processes. Thus, these chemical compounds can ameliorate disease states where angiogenesis or endothelial cell hyperproliferation is a factor. These compounds can be used to treat cancer and hyperproliferative disorders. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU6388900A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU6388900A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU6388900A3</originalsourceid><addsrcrecordid>eNrjZBAy0i2oLEqsys_JzNM11c3PSy3mYWBNS8wpTuWF0twM8m6uIc4euqkF-fGpxQWJyal5qSXxjqFmxhYWlgYGjsaEVQAAV6gezg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>2-pyrazolin-5-ones</title><source>esp@cenet</source><creator>DAVID J. CALDERWOOD ; LEE ARNOLD ; MARINA M. MOSET ; JOSE MARIA CASTELLANO BERLANGA ; ISABEL F. FERNANDEZ ; PAUL RAFFERTY</creator><creatorcontrib>DAVID J. CALDERWOOD ; LEE ARNOLD ; MARINA M. MOSET ; JOSE MARIA CASTELLANO BERLANGA ; ISABEL F. FERNANDEZ ; PAUL RAFFERTY</creatorcontrib><description>Chemical compounds having structural formula (I) and physiologically acceptable salts thereof, are inhibitors of serine/threonine and tyrosine kinase activity. Several of the tyrosine kinases, whose activity is inhibited by these chemical compounds, are involved in angiogenic processes. Thus, these chemical compounds can ameliorate disease states where angiogenesis or endothelial cell hyperproliferation is a factor. These compounds can be used to treat cancer and hyperproliferative disorders.</description><edition>7</edition><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2001</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20010219&DB=EPODOC&CC=AU&NR=6388900A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20010219&DB=EPODOC&CC=AU&NR=6388900A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DAVID J. CALDERWOOD</creatorcontrib><creatorcontrib>LEE ARNOLD</creatorcontrib><creatorcontrib>MARINA M. MOSET</creatorcontrib><creatorcontrib>JOSE MARIA CASTELLANO BERLANGA</creatorcontrib><creatorcontrib>ISABEL F. FERNANDEZ</creatorcontrib><creatorcontrib>PAUL RAFFERTY</creatorcontrib><title>2-pyrazolin-5-ones</title><description>Chemical compounds having structural formula (I) and physiologically acceptable salts thereof, are inhibitors of serine/threonine and tyrosine kinase activity. Several of the tyrosine kinases, whose activity is inhibited by these chemical compounds, are involved in angiogenic processes. Thus, these chemical compounds can ameliorate disease states where angiogenesis or endothelial cell hyperproliferation is a factor. These compounds can be used to treat cancer and hyperproliferative disorders.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2001</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBAy0i2oLEqsys_JzNM11c3PSy3mYWBNS8wpTuWF0twM8m6uIc4euqkF-fGpxQWJyal5qSXxjqFmxhYWlgYGjsaEVQAAV6gezg</recordid><startdate>20010219</startdate><enddate>20010219</enddate><creator>DAVID J. CALDERWOOD</creator><creator>LEE ARNOLD</creator><creator>MARINA M. MOSET</creator><creator>JOSE MARIA CASTELLANO BERLANGA</creator><creator>ISABEL F. FERNANDEZ</creator><creator>PAUL RAFFERTY</creator><scope>EVB</scope></search><sort><creationdate>20010219</creationdate><title>2-pyrazolin-5-ones</title><author>DAVID J. CALDERWOOD ; LEE ARNOLD ; MARINA M. MOSET ; JOSE MARIA CASTELLANO BERLANGA ; ISABEL F. FERNANDEZ ; PAUL RAFFERTY</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU6388900A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2001</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>DAVID J. CALDERWOOD</creatorcontrib><creatorcontrib>LEE ARNOLD</creatorcontrib><creatorcontrib>MARINA M. MOSET</creatorcontrib><creatorcontrib>JOSE MARIA CASTELLANO BERLANGA</creatorcontrib><creatorcontrib>ISABEL F. FERNANDEZ</creatorcontrib><creatorcontrib>PAUL RAFFERTY</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DAVID J. CALDERWOOD</au><au>LEE ARNOLD</au><au>MARINA M. MOSET</au><au>JOSE MARIA CASTELLANO BERLANGA</au><au>ISABEL F. FERNANDEZ</au><au>PAUL RAFFERTY</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>2-pyrazolin-5-ones</title><date>2001-02-19</date><risdate>2001</risdate><abstract>Chemical compounds having structural formula (I) and physiologically acceptable salts thereof, are inhibitors of serine/threonine and tyrosine kinase activity. Several of the tyrosine kinases, whose activity is inhibited by these chemical compounds, are involved in angiogenic processes. Thus, these chemical compounds can ameliorate disease states where angiogenesis or endothelial cell hyperproliferation is a factor. These compounds can be used to treat cancer and hyperproliferative disorders.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_AU6388900A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | 2-pyrazolin-5-ones |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T03%3A23%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DAVID%20J.%20CALDERWOOD&rft.date=2001-02-19&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU6388900A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |